Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJordi Bruix, Josep M. Llovet, Jean‐Luc Raoul et al.|Journal of Hepatology|2012Cited by 821
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Stefania Salvagni et al.|The Lancet Oncology|2012Cited by 550
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBernard Escudier, Vesa Kataja, Tim Eisen et al.|Annals of Oncology|2012Cited by 275
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerNicola Antonio di Meo, Giuseppe Lucarelli, Davide Loizzo et al.|International Journal of Molecular Sciences|2022Cited by 61
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive ReviewDavide Loizzo, Giuseppe Lucarelli, Savio Domenico Pandolfo et al.|International Journal of Molecular Sciences|2022Cited by 59